TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Adherence to Blood Pressure Guidelines
Brief Summary: The purpose of this study is to evaluate the impact of physician/pharmacist collaborative teams on hypertension guideline adherence for patients with uncontrolled hypertension in six family medicine practice sites in Iowa.


Options:
A: Arm Label: SMS texting intervention; Type: EXPERIMENTAL; Interventions: Behavioral: SMS texting intervention | Arm Label: Control-Usual Care; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Control-Usual Care | Intervention Type: BEHAVIORAL; Name: SMS texting intervention; Assigned to Arm(s): SMS texting intervention | Intervention Type: BEHAVIORAL; Name: Control-Usual Care; Assigned to Arm(s): Control-Usual Care
B: Arm Label: Care coordinator + Decision Support Software; Type: EXPERIMENTAL; Interventions: Other: Care Coordinator + Decision Support Software | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: OTHER; Name: Care Coordinator + Decision Support Software; Assigned to Arm(s): Care coordinator + Decision Support Software | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care
C: Arm Label: Basal Insulin Initiation Strategy; Type: EXPERIMENTAL; Interventions: Other: Basal Insulin Initiation Strategy | Arm Label: Usual Practice; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Basal Insulin Initiation Strategy; Assigned to Arm(s): Basal Insulin Initiation Strategy
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Physician-pharmacist collaborative intervention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physician-pharmacist collaborative intervention; Assigned to Arm(s): 1

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Improving Adherence to Blood Pressure Guidelines
Brief Summary: The purpose of this study is to evaluate the impact of physician/pharmacist collaborative teams on hypertension guideline adherence for patients with uncontrolled hypertension in six family medicine practice sites in Iowa.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Physician-pharmacist collaborative intervention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physician-pharmacist collaborative intervention; Assigned to Arm(s): 1
B: Intervention Type: DEVICE; Name: Electronic Medical Record (EMR) to clinician's in-basket; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: Automated Voice Message (AVM) reminder to patient's phone; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Pharmacy Team phone call-letter followup; Assigned to Arm(s): N/A
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Physician/Pharmacist Collaborative Teams | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physician/Pharmacist Collaborative Teams; Assigned to Arm(s): Intervention
D: Intervention Type: BEHAVIORAL; Name: Pharmacist intervention; Assigned to Arm(s): N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Collaborative Management of Hypertension
Brief Summary: The purpose of this study is to test whether blood pressure control can be improved by physician education and feedback provided through the development of physician/pharmacist collaborative teams.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Physician/Pharmacist Collaborative Teams | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physician/Pharmacist Collaborative Teams; Assigned to Arm(s): Intervention
B: Arm Label: Extended Treatment Group; Type: EXPERIMENTAL; Interventions: Device: Glucose and lipids, Device: Glycosylated Hemoglobin A1c, Device: Blood Pressure and Heart Rate, Device: Body mass index, Device: Waist and Hip circumference, Behavioral: Comprehensive Medication Management | Arm Label: Usual Treatment Group; Type: ACTIVE_COMPARATOR; Interventions: Device: Glucose and lipids, Device: Glycosylated Hemoglobin A1c, Device: Blood Pressure and Heart Rate, Device: Body mass index, Device: Waist and Hip circumference | Intervention Type: DEVICE; Name: Glucose and lipids; Assigned to Arm(s): Extended Treatment Group, Usual Treatment Group | Intervention Type: DEVICE; Name: Glycosylated Hemoglobin A1c; Assigned to Arm(s): Extended Treatment Group, Usual Treatment Group | Intervention Type: DEVICE; Name: Blood Pressure and Heart Rate; Assigned to Arm(s): Extended Treatment Group, Usual Treatment Group | Intervention Type: DEVICE; Name: Body mass index; Assigned to Arm(s): Extended Treatment Group, Usual Treatment Group | Intervention Type: DEVICE; Name: Waist and Hip circumference; Assigned to Arm(s): Extended Treatment Group, Usual Treatment Group | Intervention Type: BEHAVIORAL; Name: Comprehensive Medication Management; Assigned to Arm(s): Extended Treatment Group
C: Arm Label: 1; Type: N/A; Interventions: Other: 1 | Arm Label: 2; Type: N/A; Interventions: Other: 2 | Intervention Type: OTHER; Name: 1; Assigned to Arm(s): 1 | Intervention Type: OTHER; Name: 2; Assigned to Arm(s): 2
D: Arm Label: Pharmacist intervention; Type: EXPERIMENTAL; Interventions: Other: Pharmacist based QI program | Arm Label: Control - usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual Care | Intervention Type: OTHER; Name: Pharmacist based QI program; Assigned to Arm(s): Pharmacist intervention | Intervention Type: OTHER; Name: Usual Care; Assigned to Arm(s): Control - usual care

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Collaborative Management of Hypertension
Brief Summary: The purpose of this study is to test whether blood pressure control can be improved by physician education and feedback provided through the development of physician/pharmacist collaborative teams.


Options:
A: Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: Other: Case Management | Arm Label: Case Management; Type: EXPERIMENTAL; Interventions: Other: Case Management | Intervention Type: OTHER; Name: Case Management; Assigned to Arm(s): Case Management, Usual Care
B: Arm Label: Pharmacist management; Type: EXPERIMENTAL; Interventions: Behavioral: Clinical pharmacist-based intervention | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Clinical pharmacist-based intervention; Assigned to Arm(s): Pharmacist management
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Telemonitors and pharmacy management; Type: EXPERIMENTAL; Interventions: Other: Telemonitors and pharmacy management | Intervention Type: OTHER; Name: Telemonitors and pharmacy management; Assigned to Arm(s): Telemonitors and pharmacy management
D: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Physician/Pharmacist Collaborative Teams | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physician/Pharmacist Collaborative Teams; Assigned to Arm(s): Intervention

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Collaborative Management of Hypertension
Brief Summary: The purpose of this study is to test whether blood pressure control can be improved by physician education and feedback provided through the development of physician/pharmacist collaborative teams.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Physician-pharmacist collaborative intervention | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physician-pharmacist collaborative intervention; Assigned to Arm(s): 1
B: Intervention Type: DEVICE; Name: Electronic Medical Record (EMR) to clinician's in-basket; Assigned to Arm(s): N/A | Intervention Type: DEVICE; Name: Automated Voice Message (AVM) reminder to patient's phone; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Pharmacy Team phone call-letter followup; Assigned to Arm(s): N/A
C: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Other: Physician/Pharmacist Collaborative Teams | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Physician/Pharmacist Collaborative Teams; Assigned to Arm(s): Intervention
D: Intervention Type: BEHAVIORAL; Name: Pharmacist intervention; Assigned to Arm(s): N/A

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Asthma Management for Urban Teens
Brief Summary: The purpose of this project is to refine and further evaluate an online asthma management and education program for urban teenagers. This project is a continuation of Puff City I, a project piloting and evaluating a tailored, school-based, computerized asthma education program for urban teenagers. In this second phase of research, a new version of software (Puff City II) will be created that will target resistance to change and relapse, and using a tested, theory-based approach to student recruitment, conduct a randomized trial to test the efficacy of this new software.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Web-based Asthma Management | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Generic web-based asthma education | Intervention Type: BEHAVIORAL; Name: Tailored Web-based Asthma Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Generic web-based asthma education; Assigned to Arm(s): 2
B: Arm Label: Case Group; Type: N/A; Interventions: N/A | Arm Label: Control Group; Type: N/A; Interventions: Other: MyMediHealth access | Intervention Type: OTHER; Name: MyMediHealth access; Assigned to Arm(s): Control Group
C: Arm Label: Educational Program; Type: EXPERIMENTAL; Interventions: Behavioral: Educational Program | Arm Label: Asthma information for teachers; Type: NO_INTERVENTION; Interventions: Other: Usual Asthma Information for teachers | Intervention Type: BEHAVIORAL; Name: Educational Program; Assigned to Arm(s): Educational Program | Intervention Type: OTHER; Name: Usual Asthma Information for teachers; Assigned to Arm(s): Asthma information for teachers
D: Arm Label: Multifaceted intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Multifaceted intervention | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Multifaceted intervention; Assigned to Arm(s): Multifaceted intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Tailored Asthma Management for Urban Teens
Brief Summary: The purpose of this project is to refine and further evaluate an online asthma management and education program for urban teenagers. This project is a continuation of Puff City I, a project piloting and evaluating a tailored, school-based, computerized asthma education program for urban teenagers. In this second phase of research, a new version of software (Puff City II) will be created that will target resistance to change and relapse, and using a tested, theory-based approach to student recruitment, conduct a randomized trial to test the efficacy of this new software.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: Tailored Web-based Asthma Management | Arm Label: 2; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Generic web-based asthma education | Intervention Type: BEHAVIORAL; Name: Tailored Web-based Asthma Management; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Generic web-based asthma education; Assigned to Arm(s): 2
B: Arm Label: Pathological phenotype; Type: ACTIVE_COMPARATOR; Interventions: Drug: Beclometasone, Drug: Co-amoxiclav, Drug: Azithromycin | Arm Label: Clinical guidelines; Type: ACTIVE_COMPARATOR; Interventions: Drug: Beclometasone, Drug: Co-amoxiclav, Drug: Azithromycin | Intervention Type: DRUG; Name: Beclometasone; Assigned to Arm(s): Clinical guidelines, Pathological phenotype | Intervention Type: DRUG; Name: Co-amoxiclav; Assigned to Arm(s): Clinical guidelines, Pathological phenotype | Intervention Type: DRUG; Name: Azithromycin; Assigned to Arm(s): Clinical guidelines, Pathological phenotype
C: Arm Label: IVR call/text; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: IVR call/text | Arm Label: Email; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Email | Intervention Type: BEHAVIORAL; Name: IVR call/text; Assigned to Arm(s): IVR call/text | Intervention Type: BEHAVIORAL; Name: Email; Assigned to Arm(s): Email
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: AsthmaNet | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: AsthmaNet; Assigned to Arm(s): 1

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Hypertension Improvement Project (HIP)
Brief Summary: This study will test the separate and combined effects of a continuous quality improvement (CQI) intervention for physicians (MDs) and a behavioral intervention for patients on blood pressure control.


Options:
A: Arm Label: MD-C/PT-C; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: MD-I/PT-C; Type: EXPERIMENTAL; Interventions: Behavioral: MD CQI-type intervention | Arm Label: MD-C/Pt-I; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle interventions to lower blood pressure for patients | Arm Label: MD-I/Pt-I; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle interventions to lower blood pressure for patients, Behavioral: MD CQI-type intervention | Intervention Type: BEHAVIORAL; Name: Lifestyle interventions to lower blood pressure for patients; Assigned to Arm(s): MD-C/Pt-I, MD-I/Pt-I | Intervention Type: BEHAVIORAL; Name: MD CQI-type intervention; Assigned to Arm(s): MD-I/PT-C, MD-I/Pt-I
B: Intervention Type: PROCEDURE; Name: meeting nurses / physicians, quality improvement sessions; Assigned to Arm(s): N/A
C: Arm Label: Early Feedback Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Publicly released hospital cardiac report cards | Arm Label: Delayed Feedback Arm; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Publicly released hospital cardiac report cards | Intervention Type: BEHAVIORAL; Name: Publicly released hospital cardiac report cards; Assigned to Arm(s): Delayed Feedback Arm, Early Feedback Arm
D: Arm Label: minimal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: professional audit and feedback (guideline adherence) | Arm Label: maximal intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: patient education, Behavioral: professional audit and feedback (guideline adherence), Behavioral: professional education (communication/shared decision making), Other: information tools | Intervention Type: BEHAVIORAL; Name: patient education; Assigned to Arm(s): maximal intervention | Intervention Type: BEHAVIORAL; Name: professional audit and feedback (guideline adherence); Assigned to Arm(s): maximal intervention, minimal intervention | Intervention Type: BEHAVIORAL; Name: professional education (communication/shared decision making); Assigned to Arm(s): maximal intervention | Intervention Type: OTHER; Name: information tools; Assigned to Arm(s): maximal intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Trial of GM-CSF in Patients With ALI/ARDS
Brief Summary: This study will test the hypothesis that administration of granulocyte-macrophage colony stimulating factor (GM-CSF) to patients with acute lung injury/acute respiratory distress syndrome (ALI/ARDS) will improve the clinical course and outcome by shortening the duration of mechanical ventilation for these patients.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: GM-CSF | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: GM-CSF; Assigned to Arm(s): 1
B: Arm Label: AP301; Type: EXPERIMENTAL; Interventions: Drug: AP301 | Arm Label: saline solution; Type: PLACEBO_COMPARATOR; Interventions: Drug: Saline solution | Intervention Type: DRUG; Name: AP301; Assigned to Arm(s): AP301 | Intervention Type: DRUG; Name: Saline solution; Assigned to Arm(s): saline solution
C: Intervention Type: PROCEDURE; Name: pulmonary artery catheter; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: central venous catheter; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: fluid management; Assigned to Arm(s): N/A
D: Arm Label: Rosuvastatin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Rosuvastatin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Rosuvastatin; Assigned to Arm(s): Rosuvastatin | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale
Brief Summary: The primary objective of the study is to determine whether the STARFlex® septal closure system will safely and effectively prevent a recurrent embolic stroke/transient ischemic attack (TIA) and mortality in patients with a PFO and to demonstrate superiority of the STARFlex® device compared to best medical therapy.


Options:
A: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Drug: Best medical therapy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Device: STARFlex septal closure system | Intervention Type: DEVICE; Name: STARFlex septal closure system; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: Best medical therapy; Assigned to Arm(s): 1
B: Arm Label: Antiplatelet; Type: ACTIVE_COMPARATOR; Interventions: Drug: aspirin, Drug: clopidogrel, Other: placebo | Arm Label: Blood pressure; Type: ACTIVE_COMPARATOR; Interventions: Other: Target of Blood Pressure | Intervention Type: DRUG; Name: aspirin; Assigned to Arm(s): Antiplatelet | Intervention Type: DRUG; Name: clopidogrel; Assigned to Arm(s): Antiplatelet | Intervention Type: OTHER; Name: Target of Blood Pressure; Assigned to Arm(s): Blood pressure | Intervention Type: OTHER; Name: placebo; Assigned to Arm(s): Antiplatelet
C: Arm Label: Combination Clopidogrel and asprin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Clopidogrel | Arm Label: Asprin and placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo of clopidogrel and Asprin | Intervention Type: DRUG; Name: Clopidogrel; Assigned to Arm(s): Combination Clopidogrel and asprin | Intervention Type: DRUG; Name: Placebo of clopidogrel and Asprin; Assigned to Arm(s): Asprin and placebo
D: Arm Label: ticagrelor; Type: EXPERIMENTAL; Interventions: Drug: ticagrelor | Arm Label: Acetylsalicylic acid (ASA); Type: ACTIVE_COMPARATOR; Interventions: Drug: Acetylsalicylic acid (ASA) | Intervention Type: DRUG; Name: ticagrelor; Assigned to Arm(s): ticagrelor | Intervention Type: DRUG; Name: Acetylsalicylic acid (ASA); Assigned to Arm(s): Acetylsalicylic acid (ASA)

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of Stabilizing Exercises and Effect on Anticipatory Muscle Control in Patients With Subacute and Chronic Low Back Pain
Brief Summary: Muscular stability is essential to the spinal column to avoid harmful strain and injury to its structures. Sudden postural disturbances impose reactive internal forces through the spine. If the muscles do not react before the internal reactive forces propagate through the spine, there is a short fraction of time where the spinal column may lack sufficient muscular support. Studies have shown that in patients with low back pain deep abdominal and back muscle have a delayed response to reactive forces. The purpose of this study is to verify these findings and to investigate whether tailored interventions can improve the reaction time in stabilizing muscle around the lower spinal column i patients with subacute and chronic low back pain.


Options:
A: Arm Label: TrA exercise; Type: EXPERIMENTAL; Interventions: Behavioral: Isolated Transversus abdominis (TrA) exercise | Arm Label: sling exercise; Type: EXPERIMENTAL; Interventions: Behavioral: sling exercise | Arm Label: group exercise; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: group exercise | Intervention Type: BEHAVIORAL; Name: Isolated Transversus abdominis (TrA) exercise; Assigned to Arm(s): TrA exercise | Intervention Type: BEHAVIORAL; Name: sling exercise; Assigned to Arm(s): sling exercise | Intervention Type: BEHAVIORAL; Name: group exercise; Assigned to Arm(s): group exercise
B: Intervention Type: PROCEDURE; Name: Mod. functional restoration-Individ. dynamic back-muscle; Assigned to Arm(s): N/A
C: Intervention Type: PROCEDURE; Name: Chiropractic Spinal Manipulation; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: Exercise; Assigned to Arm(s): N/A | Intervention Type: BEHAVIORAL; Name: Self-care; Assigned to Arm(s): N/A
D: Arm Label: Graded Activity; Type: ACTIVE_COMPARATOR; Interventions: Other: Graded Activity, Other: Supervised Exercises | Arm Label: Supervised exercises; Type: ACTIVE_COMPARATOR; Interventions: Other: Graded Activity, Other: Supervised Exercises | Intervention Type: OTHER; Name: Graded Activity; Assigned to Arm(s): Graded Activity, Supervised exercises | Intervention Type: OTHER; Name: Supervised Exercises; Assigned to Arm(s): Graded Activity, Supervised exercises

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Multicenter, Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of the Effects of Titrated Oral Tolvaptan Tablets in Patients With Hyponatremia, Study 2
Brief Summary: This study's purpose is to determine whether tolvaptan can safely and effectively return the body's balance of sodium and water toward normal, and to characterize and quantify the potential clinical benefits of this treatment.


Options:
A: Arm Label: Tolvaptan; Type: EXPERIMENTAL; Interventions: Drug: Tolvaptan | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tolvaptan; Assigned to Arm(s): Tolvaptan | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Satavaptan; Type: EXPERIMENTAL; Interventions: Drug: Satavaptan | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: Satavaptan; Assigned to Arm(s): Satavaptan | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo
C: Intervention Type: DRUG; Name: Tolvaptan; Assigned to Arm(s): N/A
D: Intervention Type: DRUG; Name: tolvaptan; Assigned to Arm(s): N/A

Answer: C